Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8381805eba6d034fc77bd230dd02e6e2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2299-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1055 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 |
filingDate |
2003-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8ecd65448f82c1e9f89fdee09415ab8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee4f1e31c05982140105efc0b93e8632 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d24b5e99e16dab3982bdfa64139ba08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8171fd54539cc048f907967514fd7274 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8a60164d682c2155f47feaae7e11563 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d38ab50a11c23096e9dc038900388951 |
publicationDate |
2005-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1576128-A2 |
titleOfInvention |
Products and processes for modulating peptide-peptide binding domain interactions |
abstract |
The present invention relates to therapeutic compounds and methods of use of these therapeutic compounds for treating cellular proliferative disorders. The invention also provides three-dimensional structures of a Polo-like kinase and methods for designing or selecting small molecule inhibitors using these structures, and the therapeutic use of such compounds. The invention also includes a method for identifying novel phosphopeptide-binding domains. |
priorityDate |
2002-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |